MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

New Connected Devices Seek to Tackle Drug Noncompliance

Could data-generating devices give patients and physicians more insights into behavior?

Connected MDI - image courtesy of Aptar Pharma 

Noncompliance with drug regimens continues to be a significant healthcare concern. “Today, 60% of patients fail to comply with their medication regimen,” Sai Shankar, director business development - connected devices for Aptar Pharma, tells MD+DI.
Aptar Pharma believes that turning metered-dose inhalers (MDIs) and dry-powder inhalers (DPIs) into connected devices could have an impact. “This can improve patient engagement and significantly increase dose adherence and improve patient health outcomes, as patients manage their treatments more effectively,” says Shankar. “Connected devices provide objective monitoring and real-time data with digital solutions. This improves patient adherence, which reduces hospitalization events in chronic diseases. Hospitalization reduction decreases costs to payers, creating value in healthcare system.”
Aptar Pharma is partnering with a digital health solution provider to develop a portfolio of connected devices such as MDIs and DPIs. “Aptar Pharma offers drug-delivery devices that can bring in the full connected functionality and integrate them with software solutions that are accessible to patients/consumers,” he says.
The company will be highlighting several technologies at the upcoming CPhI Worldwide on October 24-26, 2017, at Messe Frankfurt, Germany.
“For respiratory, we will be featuring our c-Devices portfolio at CPhI, which includes our connected pMDI, connected BAI Platform, and Connected Prohaler devices," Shankar says. "We are also partnering with KaliCare on connected solutions for EyeCare, and will be featuring those connected devices as well."
Shankar and other members from the Aptar Pharma team will be speaking about drug-delivery devices at CPhI:
Tuesday, October 24 at 10.30: Guenter Nadler, Director Business Development – “Innovative respiratory solutions for expanding your product portfolio
Tuesday, October 24 at 15.50: Sai Shankar, Business Development Director for Connected Devices – “Driving better patient outcomes with connectivity
Wednesday, October 25 at 10.30: Arnaud Fournier, Business Support Manager Injectables – “Setting new standards for coated stoppers
For more details, visit Aptar Pharma at CPhI stand 42F10.
And be sure to check out these educational opportunities at MD&M Minneapolis in November:
  • "Workshop: Transforming Healthcare with Augmented & Virtual Reality" by
    Brandon Bogdalek, business development manager, Worrell
  • "Deep Design: Using Technology to Improve Clinical Work Processes" by Kathleen Harder, PhD; Director, Center for Design in Health, University of Minnesota
  • "How Usability Research & Engineering Are Changing Medical Device Development" by Sean Hagen (BlackHagen Design) and Michael Lynch (Intertek)
  • "Case Study: How Human-Centered Design Disrupted Cancer Treatment," by Mu Young Lee (Varian Medical Systems)
  • "Top 6 IoT Design Strategies for Success" by Gianfranco Bonanome, director of IoT Solutions, Intelligent Product Solutions
Filed Under

500 characters remaining
Very informative writing on this topic . You may know JSC Result 2017 is published by Education Board. To know your JSC Result 2017 click on the official site. <a href="">JSC Result 2017</a>
Nice writing on this important topic. Thanks for sharing. See the new ways and to make a new blog successful in below. How to Start a Blog >>>